SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 2154600

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 2154600

Ultrasonic Microbubble Contrast Agents Market - Global Forecast 2026-2032

PUBLISHED:
PAGES: 191 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (1-5 Users License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 5959

Add to Cart

The Ultrasonic Microbubble Contrast Agents Market is projected to grow by USD 2.28 billion at a CAGR of 9.30% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.22 billion
Estimated Year [2026] USD 1.34 billion
Forecast Year [2032] USD 2.28 billion
CAGR (%) 9.30%

Ultrasonic Microbubble Contrast Agents: Executive Overview

Ultrasonic microbubble contrast agents enhance ultrasound visualization by producing strong acoustic responses that improve the detection and characterization of blood flow, perfusion, and selected lesions. Their clinical relevance is tied to ultrasound's portability, real-time imaging, absence of ionizing radiation, and expanding use in abdominal, cardiovascular, vascular, and oncology-related assessment. Adoption depends on validated clinical utility, regulatory authorization, operator expertise, reimbursement conditions, and reliable access to imaging equipment and trained personnel.

Clinical Integration Is Reshaping Contrast-Enhanced Ultrasound

The landscape is shifting from contrast agents being used primarily for specialized examinations toward broader integration into diagnostic workflows where conventional ultrasound or other imaging methods leave uncertainty. Greater emphasis on standardized protocols, image quality, safety monitoring, and reproducible interpretation is supporting more consistent clinical use. Additional change is coming from point-of-care imaging, improved transducer technology, workflow digitization, and efforts to reduce avoidable referrals or repeat examinations while preserving diagnostic confidence.

Artificial Intelligence Is Increasing the Value of Microbubble-Enhanced Imaging

Artificial intelligence is contributing to the cumulative impact of microbubble-enhanced ultrasound through automated image quality assessment, lesion detection, motion correction, perfusion quantification, and decision support. These tools can help clinicians interpret dynamic contrast behavior and reduce variability between operators, but their usefulness depends on representative training data, transparent validation, interoperability, and safeguards against automation bias. Evidence generation should therefore assess AI-enabled workflows against clinically meaningful outcomes rather than relying solely on technical performance metrics.

Regional Dynamics Reflect Uneven Access and Different Clinical Priorities

North America is characterized by established advanced-imaging infrastructure, specialist adoption, and attention to reimbursement and evidence requirements. Europe combines mature hospital systems with strong emphasis on safety, cross-border regulation, and standardized clinical practice. Asia-Pacific presents substantial diversity, with advanced adoption in countries such as Japan, South Korea, and Australia alongside capacity-building needs in other markets. Latin America is influenced by uneven access to equipment, specialist training, and public-sector funding. The Middle East is developing advanced diagnostic capacity through hospital modernization, while Africa continues to face constraints involving infrastructure, workforce availability, procurement, and maintenance. Across all regions, local clinical guidelines, regulatory pathways, and supply reliability materially affect implementation.

Economic and Political Groups Shape Procurement, Standards, and Access

ASEAN markets differ considerably in regulatory maturity, healthcare financing, and specialist availability, making regional harmonization and training particularly relevant. BRICS members span highly varied health systems and manufacturing capabilities, with access shaped by public procurement, domestic production, and urban-rural disparities. The European Union benefits from coordinated regulatory structures while retaining national differences in reimbursement and clinical adoption. G7 countries generally have advanced imaging ecosystems but face evidence, cost-effectiveness, and workforce pressures. GCC countries are investing in sophisticated hospital capacity and centralized procurement, whereas NATO members reflect a broad range of health-system maturity and may emphasize resilience, interoperability, and continuity of diagnostic services.

Country-Level Priorities Range from Innovation Leadership to Capacity Building

Australia emphasizes evidence-based imaging, rural access, and workforce distribution. Brazil and Mexico face the dual challenge of expanding advanced diagnostics while addressing regional inequality and public-sector resource constraints. Canada and the United States have sophisticated imaging capabilities, with adoption influenced by clinical evidence, reimbursement, accreditation, and specialist availability. China is strengthening domestic healthcare capacity and technology development, while India is balancing rapid urban growth with major access gaps outside metropolitan centers. Japan and South Korea have advanced ultrasound expertise and strong technology adoption. France, Germany, Italy, Spain, and the United Kingdom are shaped by established healthcare systems, regulatory compliance, budget discipline, and differing reimbursement pathways. Russia's operating environment is influenced by healthcare modernization, supply continuity, and access to specialized technology.

Priorities for Leaders: Prove Utility, Build Capability, and Secure Access

Industry leaders should prioritize evidence that demonstrates how microbubble-enhanced ultrasound changes diagnosis, treatment planning, monitoring, or referral decisions. They should develop training programs covering patient selection, administration, image acquisition, interpretation, and adverse-event readiness, with content adapted to local practice. Partnerships with hospitals and professional societies can support protocol standardization and real-world validation. Organizations should also strengthen supply resilience, provide interoperable workflow tools, and evaluate AI features through transparent governance. Market access planning should address regulatory documentation, reimbursement evidence, procurement requirements, and equitable deployment across urban and underserved settings.

Methodology: Evidence-Led Assessment of Clinical and Operating Conditions

This executive summary uses a structured qualitative assessment of ultrasonic microbubble contrast agents across clinical adoption, technology development, healthcare infrastructure, regulation, reimbursement, workforce, procurement, and regional access conditions. The analysis organizes findings across the specified regions, economic and political groups, and countries, while distinguishing established applications from emerging opportunities. It excludes market estimates, market shares, forecasts, company-specific claims, and unsupported performance assertions. Interpretation should be updated as clinical guidelines, regulatory decisions, reimbursement policies, safety evidence, and AI validation studies evolve.

Conclusion: Sustainable Adoption Depends on Demonstrated Clinical Value

Ultrasonic microbubble contrast agents occupy an important position at the intersection of advanced ultrasound, minimally invasive diagnosis, and increasingly data-driven clinical care. Their continued adoption will depend less on technical novelty alone than on reliable evidence, skilled users, integrated workflows, responsible AI, and equitable access to equipment and expertise. Leaders that connect product development with clinical outcomes, education, regulatory readiness, and resilient delivery will be better positioned to support durable use across diverse healthcare systems.

Product Code: MRR-537DB9F46E58

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Ultrasonic Microbubble Contrast Agents Market, by Product Type

  • 7.1. Introduction
  • 7.2. Multi Bubble
  • 7.3. Single Bubble
  • 7.4. Targeted Agent

8. Ultrasonic Microbubble Contrast Agents Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular
  • 8.3. Gastroenterology
  • 8.4. Oncology
    • 8.4.1. Breast Cancer
    • 8.4.2. Liver Cancer
    • 8.4.3. Lung Cancer
  • 8.5. Urology

9. Ultrasonic Microbubble Contrast Agents Market, by End User

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Diagnostic Centers
  • 9.4. Hospitals
    • 9.4.1. Secondary Care
    • 9.4.2. Tertiary Care

10. Ultrasonic Microbubble Contrast Agents Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacy
  • 10.3. Online Pharmacy
  • 10.4. Retail Pharmacy

11. Ultrasonic Microbubble Contrast Agents Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Ultrasonic Microbubble Contrast Agents Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Ultrasonic Microbubble Contrast Agents Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Advanced Microbubbles Inc.
  • 15.2. Aspect Imaging Ltd.
  • 15.3. BCM Technologies, Inc.
  • 15.4. Biocell Technology LLC
  • 15.5. Bracco Suisse SA
  • 15.6. Canon Medical Systems Corporation
  • 15.7. CURASIS GmbH
  • 15.8. Daiichi Sankyo Company, Limited
  • 15.9. Esaote SpA
  • 15.10. Fujifilm Holdings Corporation
  • 15.11. GE Healthcare AS
  • 15.12. Hitachi, Ltd.
  • 15.13. Lantheus Medical Imaging, Inc.
  • 15.14. Mallinckrodt plc
  • 15.15. Microbubble Therapeutics Pty Ltd
  • 15.16. Mindray Medical International Limited
  • 15.17. Samsung Medison Co., Ltd.
  • 15.18. Siemens Healthineers AG
  • 15.19. Targeson, Inc.

16. Key Experts

Product Code: MRR-537DB9F46E58

LIST OF FIGURES

  • FIGURE 1. Global Ultrasonic Microbubble Contrast Agents Market, Years Considered for the Study
  • FIGURE 2. Global Ultrasonic Microbubble Contrast Agents Market, Research Design
  • FIGURE 3. Global Ultrasonic Microbubble Contrast Agents Market, Research Framework
  • FIGURE 4. Global Ultrasonic Microbubble Contrast Agents Market, Data Triangulation
  • FIGURE 5. Global Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 9. Global Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 11. Global Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 13. Global Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Ultrasonic Microbubble Contrast Agents Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Ultrasonic Microbubble Contrast Agents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Ultrasonic Microbubble Contrast Agents Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Ultrasonic Microbubble Contrast Agents Market Segmentation & Coverage
  • TABLE 2. Global Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Multi Bubble Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Multi Bubble Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Multi Bubble Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Single Bubble Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Single Bubble Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Single Bubble Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Targeted Agent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Targeted Agent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Targeted Agent Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 14. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Gastroenterology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Gastroenterology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Gastroenterology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Liver Cancer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Liver Cancer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Liver Cancer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Urology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Urology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Urology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 36. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Secondary Care Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Secondary Care Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Secondary Care Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Tertiary Care Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Tertiary Care Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Tertiary Care Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 52. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 64. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 65. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 66. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 67. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 68. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 69. North America Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. North America Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 71. North America Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 72. North America Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 73. North America Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 74. North America Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 75. North America Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 76. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 77. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 78. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 79. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 80. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 81. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 82. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 83. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 85. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 86. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 87. Europe Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 88. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 89. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 90. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 91. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 92. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 93. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 94. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 95. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 96. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 97. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 99. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 100. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 101. Africa Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 102. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 103. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 104. Global Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 105. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 107. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 108. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 109. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 110. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 111. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 112. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 113. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 114. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 115. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 116. GCC Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 117. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 118. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 119. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 120. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 121. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 122. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 123. European Union Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 124. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 125. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 126. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 128. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 129. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 130. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 131. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 132. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 133. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 134. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 135. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 136. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 137. G7 Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 138. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 139. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 140. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 141. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 142. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 143. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 144. NATO Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 145. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 146. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 147. Global Ultrasonic Microbubble Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 148. United States Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 149. United States Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 150. United States Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 151. United States Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 152. United States Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 153. United States Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 154. United States Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 155. Canada Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 156. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 157. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 158. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 159. Canada Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 160. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 161. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 162. Mexico Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 163. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 164. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 165. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 166. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 167. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 168. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 169. Brazil Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 170. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 171. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 172. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 173. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 174. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 175. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 176. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 177. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 178. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 179. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 180. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 181. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 182. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 183. Germany Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 184. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 185. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 186. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 187. Germany Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 188. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 189. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 190. France Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 191. France Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 192. France Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 193. France Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 194. France Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 195. France Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 196. France Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 197. Russia Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 198. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 199. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 200. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 201. Russia Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 202. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 203. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 204. Italy Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 205. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 206. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 207. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 208. Italy Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 209. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 210. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 211. Spain Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 212. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 213. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 214. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 215. Spain Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 216. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 217. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 218. China Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 219. China Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 220. China Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 221. China Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 222. China Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 223. China Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 224. China Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 225. India Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 226. India Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 227. India Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 228. India Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 229. India Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 230. India Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 231. India Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 232. Japan Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 233. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 234. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 235. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 236. Japan Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 237. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 238. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 239. Australia Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 240. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 241. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 242. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 243. Australia Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 244. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 245. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 246. South Korea Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
  • TABLE 247. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 248. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 249. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 250. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 251. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 252. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 253. Global Ultrasonic Microbubble Contrast Agents Market Share, by Key Player, 2025
  • TABLE 254. Global Ultrasonic Microbubble Contrast Agents Market, Key Experts
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!